Clinical Trials on Narcotic-Related Disorders

Total 161356 results

University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder
Gazi University

Recruiting

Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process

Opioid Use Disorder

Turkey
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Aptinyx

Recruiting

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder (VA-BRAVE)

Opioid Use Disorder

United States
AstraZeneca

Completed

A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

Opioid Use Disorder

United States
Center for Social Innovation, Massachusetts
West Haven VA

Completed

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
3D Therapy, LLC

Completed

The Feasibility of VR for OUD

Opioid Use Disorder

United States
Johns Hopkins University

Withdrawn

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Opioid Use Disorder
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Carilion Clinic

Completed

START NOW in the Treatment of Opioid Addicted Individuals

Opioid Use Disorder

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Terminated

A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders

Opioid Use Disorder

United States
Butler Hospital

Withdrawn

Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment

Opioid Use Disorder

United States
Dartmouth-Hitchcock Medical Center

Completed

MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence (MySafeRx)

Opioid Use Disorder

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

Opioid Use Disorder

United States
Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Laura and John Arnold Foundation

Completed

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail (SOMATICS FRI)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
NYU Langone Health

Completed

TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

Opioid Use Disorder

United States
Alkermes, Inc.

Completed

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

Opioid Use Disorder

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Sex and Female Empowerment (SAFE)

Opioid Use Disorder

United States
Indivior Inc.

Completed

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Opioid Use Disorder

United States
Member Companies of the Opioid PMR Consortium
Kaiser Permanente; World Health Information Science Consultants, LLC

Completed

An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
Elizabeth Krans, MD
National Institute on Drug Abuse (NIDA); OpalGenix, Inc

Recruiting

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Pregnancy Related | Opioid Use Disorder

United States
University of South Florida

Active, not recruiting

Continuous And Data-drivEN CarE (CADENCE) Pilot (CADENCE)

Pregnancy Related | Opioid Use Disorder

United States
Washington State University

Not yet recruiting

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment (MIRROM)

Stimulant Use Disorder
William Stoops
National Institute on Drug Abuse (NIDA)

Recruiting

Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine) (BED IN 43)

Opioid Use Disorder | Cocaine Use Disorder

United States
Johns Hopkins University

Recruiting

Suvorexant for Opioid/Stimulant Co-use

Opioid Use Disorder | Stimulant Use Disorder

United States
Rowan University
The Cooper Health System

Recruiting

Increasing MAT Engagement With Financial Incentives

Opioid-use Disorder

United States
New York State Psychiatric Institute
Clinilabs, Inc.

Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Allegheny Singer Research Institute (also known...
Abbott

Recruiting

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Opioid-Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

Opioid-use Disorder

United States
Mclean Hospital

Completed

Stress Response in Opioid Use Disorder

Opioid-use Disorder

United States
Denver Health and Hospital Authority
Centers for Disease Control and Prevention

Completed

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder (ConNECT)

Opioid-use Disorder

United States
Rutgers University

Completed

Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder

Opioid-use Disorder

United States
Yale University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Treatment of Pregnant Women With OUD (SMART)

Opioid-use Disorder

United States
Michele Staton
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Kentucky Women's Justice Community Opioid Innovation Network (W-JCOIN)

Opioid-use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
Kaiser Permanente
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial (PROUD)

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
University of Delaware
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Completed

Disclosure Intervention for People in Recovery From Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Opioid-use Disorder

United States
University of Minnesota

Active, not recruiting

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Opioid Use Disorder | Stimulant Use Disorder

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA); Dartmouth College; Kaiser Permanente; National...

Completed

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT)

Opioid-use Disorder

United States
PhotoPharmics, Inc.
National Institute on Drug Abuse (NIDA); Brigham Young University

Completed

Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety

Opioid-use Disorder

United States

Clinical Trials on Narcotic-Related Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations